UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000061682
Receipt number R000070575
Scientific Title Study of artistic creativity assessment in children using exercises.
Date of disclosure of the study information 2026/05/25
Last modified on 2026/05/25 18:03:30

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study of artistic creativity assessment in children using exercises.

Acronym

Study of exercises and artistic creativity.

Scientific Title

Study of artistic creativity assessment in children using exercises.

Scientific Title:Acronym

Study of exercises and artistic creativity.

Region

Japan


Condition

Condition

Healthy person

Classification by specialty

Not applicable Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effects of exercise on the artistic quality of artwork.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Art rating.

Key secondary outcomes

Cognitive task performance.
Autonomic nerve function.
Subjective sensation.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

The intervention involves performing exercises during the creation of artwork.

Interventions/Control_2

Providing instructions on the exercises only during the creation of artwork.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

9 years-old <=

Age-upper limit

15 years-old >=

Gender

Male and Female

Key inclusion criteria

(1) Individuals who are in Grade 4 of elementary school through Grade 3 of junior high school and do not meet the exclusion criteria.
(2) Those who can understand the informed consent content and are able to provide written assent voluntarily, and whose parent or guardian is able to provide written informed consent.

Key exclusion criteria

(1) Individuals who have a history of serious neurological, cardiovascular, or other serious diseases, or who are currently undergoing treatment, including the use of prescription medications provided by a medical institution.
(2) Individuals who have a history of seizures related to neurological disorders, including episodes of loss of consciousness, coma, or convulsions.
(3) Individuals deemed unsuitable for participation in the study by the principal investigator.

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Kei
Middle name
Last name Mizuno

Organization

Osaka Metropolitan University

Division name

Center for Health Science Innovation

Zip code

5588585

Address

3-3-138 Sugimoto, Sumiyoshi-ku, Osaka City, JAPAN

TEL

+81-6-6605-3432

Email

gr-knky-chsi@omu.ac.jp


Public contact

Name of contact person

1st name Kei
Middle name
Last name MIZUNO

Organization

Osaka Metropolitan University

Division name

Center for Health Science Innovation

Zip code

5588585

Address

3-3-138 Sugimoto, Sumiyoshi-ku, Osaka City, JAPAN

TEL

+81-6-6605-3432

Homepage URL


Email

gr-knky-chsi@omu.ac.jp


Sponsor or person

Institute

Osaka Metropolitan University Center for Health Science Innovation

Institute

Department

Personal name



Funding Source

Organization

Shiga Support Center of Culture and Art for Next Generation.

Organization

Division

Category of Funding Organization

Local Government

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Osaka Metropolitan University Center for Health Science Innovation Ethics Committee

Address

3-3-138 Sugimoto, Sumiyoshi-ku, Osaka City, JAPAN

Tel

+81-6-6605-3432

Email

gr-knky-chsi@omu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 05 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 05 Month 06 Day

Date of IRB

2026 Year 05 Month 11 Day

Anticipated trial start date

2026 Year 06 Month 15 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 05 Month 25 Day

Last modified on

2026 Year 05 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000070575